Annual Accounts Payable
$2.44 M
-$99.00 K-3.90%
December 31, 2023
Summary
- As of February 8, 2025, VIRX annual accounts payable is $2.44 million, with the most recent change of -$99.00 thousand (-3.90%) on December 31, 2023.
- During the last 3 years, VIRX annual accounts payable has risen by +$884.00 thousand (+56.78%).
- VIRX annual accounts payable is now -15.86% below its all-time high of $2.90 million, reached on December 31, 2021.
Performance
VIRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.82 M
+$531.00 K+41.29%
September 30, 2024
Summary
- As of February 8, 2025, VIRX quarterly accounts payable is $1.82 million, with the most recent change of +$531.00 thousand (+41.29%) on September 30, 2024.
- Over the past year, VIRX quarterly accounts payable has dropped by -$624.00 thousand (-25.56%).
- VIRX quarterly accounts payable is now -43.82% below its all-time high of $3.23 million, reached on June 30, 2023.
Performance
VIRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VIRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.9% | -25.6% |
| 3 y3 years | +56.8% | -25.6% |
| 5 y5 years | +56.8% | -25.6% |
VIRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -15.9% | at low | -43.8% | +41.3% |
| 5 y | 5-year | -15.9% | +56.8% | -43.8% | +41.3% |
| alltime | all time | -15.9% | +56.8% | -43.8% | +41.3% |
Viracta Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.82 M(+41.3%) |
| Jun 2024 | - | $1.29 M(-46.7%) |
| Mar 2024 | - | $2.41 M(-1.2%) |
| Dec 2023 | $2.44 M(-3.9%) | $2.44 M(+3.3%) |
| Sep 2023 | - | $2.36 M(-26.9%) |
| Jun 2023 | - | $3.23 M(+55.5%) |
| Mar 2023 | - | $2.08 M(-18.1%) |
| Dec 2022 | $2.54 M | $2.54 M(+57.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.62 M(-11.5%) |
| Jun 2022 | - | $1.83 M(-43.3%) |
| Mar 2022 | - | $3.22 M(+11.1%) |
| Dec 2021 | $2.90 M(+86.3%) | $2.90 M(+38.3%) |
| Sep 2021 | - | $2.10 M(-18.2%) |
| Jun 2021 | - | $2.57 M(+63.3%) |
| Mar 2021 | - | $1.57 M(+0.9%) |
| Dec 2020 | $1.56 M | $1.56 M |
FAQ
- What is Viracta Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Viracta Therapeutics?
- What is Viracta Therapeutics annual accounts payable year-on-year change?
- What is Viracta Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly accounts payable year-on-year change?
What is Viracta Therapeutics annual accounts payable?
The current annual accounts payable of VIRX is $2.44 M
What is the all time high annual accounts payable for Viracta Therapeutics?
Viracta Therapeutics all-time high annual accounts payable is $2.90 M
What is Viracta Therapeutics annual accounts payable year-on-year change?
Over the past year, VIRX annual accounts payable has changed by -$99.00 K (-3.90%)
What is Viracta Therapeutics quarterly accounts payable?
The current quarterly accounts payable of VIRX is $1.82 M
What is the all time high quarterly accounts payable for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly accounts payable is $3.23 M
What is Viracta Therapeutics quarterly accounts payable year-on-year change?
Over the past year, VIRX quarterly accounts payable has changed by -$624.00 K (-25.56%)